19 clinical trials matched your search for Solid Tumors. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Cancer A Study for Patients with Advanced Melanoma, Solid Tumors or Lymphoma Using Study Drug Pembrolizumab Nobuko Hijiya, MD
Cancer Study of IDE196 in Patients with Solid Tumors Alexander Wei, MD
Cancer Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors Catherine Shu, MD
Cancer A Study of BMS-986340 Alone and in Combination With Nivolumab in Participants With Advanced Solid Tumors Ryan Moy, MD
Cancer Study of IDE397 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Cancer Study of STK-012 Alone or in Combination with Pembrolizumab (KEYTRUDA) in Patients with Advanced Solid Tumors Benjamin Izar, MD
Cancer Study of MRT-2359 in Patients with Solid Tumors Benjamin Herzberg, MD
Cancer Study of RMC-6236 in Patients with Solid Tumors with a KRAS Mutation Benjamin Herzberg, MD
Brain Cancer Study of PF-07799544 in Patients with Solid Brain Tumors Aya Haggiagi, MD
Brain Tumors Study of PF-07799544 in Patients with Solid Brain Tumors Aya Haggiagi, MD
Cancer Study of T Plex in Patients with Advanced or Metastatic Solid Tumors Brian Henick, MD
Cancer Study of DB-1311 in Patients with Solid Tumors Brian Henick, MD
Cancer Study of RMC-6291 and RMC 6236 in Patients with Solid Tumors Benjamin Herzberg, MD
Cancer Study of SGN-B6A in Advanced Solid Tumors Benjamin Herzberg, MD
Bladder Cancer A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (LOXO-LNC-24001) Alexander Wei, MD
Breast Cancer Study of RLY-2608 in Patients with Breast Cancer Julia McGuinness, MD
Cancer Study of ASP3082 in Patients with Advanced Cancer with a KRAS G12D Mutation Benjamin Herzberg, MD
Cancer Study of 68Ga-FAP-2286 and 177Lu-FAP-2286 in Patients with Advanced Cancer Ryan Moy, MD
Gynecologic Cancer Study of TransCon IL-2 / vs. TransCon TLR7/8 Agonist in Patients with Gynecologic Cancer June Hou, MD
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE